Journal of Bioanalysis & Biomedicine

4^th International Conference and Exhibition on Biologics & Biosimilars

October 26-28, 2015 Baltimore, USA

Posters-Accepted Abstracts

• Identification and quantification of flavonoids and their glycosides for quality assessment of Terminalia species applying liquid chromatography hyphenated with mass spectrometric techniques

  Awantika Singh, Vikas Bajpai, Sunil Kumar and Brijesh Kumar

  PDF HTML

• Characterisation of Insulin Analogues

  Livk A, Tan P, Judge Azevedo R, Lui J, Lipscombe R and Morrison C*

  PDF HTML

• Patients satisfaction on anti-retroviral therapy monitoring laboratory services in public hospitals, Addis Ababa, Ethiopia

  Tedla Mindaye

  PDF HTML

• Improving injection force of high viscous drugs by a unique, commercially available needle created by using tapered technology

  Mitsuru Takahashi

  PDF HTML

• Structural modification of the alpha-helical antimicrobial brevinin-2 related peptide: A comparison study of biosimilars

  Siqin Liu

  PDF HTML

• Ultra performance liquid chromatography mass spectrometric analysis for rapid quantitation of isoquinoline alkaloids in Thalictrum reniforme

  Vikas Bajpai, Awantika Singh, Sunil Kumar and Brijesh Kumar

  PDF HTML

• Cold active endo-glucanase from Antarctic yeast, Glaciozyma antarctica PI12: Expression and characterization

  Salimeh Mohammadi

  PDF HTML

• Biosimilars: Challenges and developments

  Samer M Al-Hulu

  PDF HTML

• Study of the antiulcer activity of the essential oil of the Cupressaceae tree Juniperus phoenicea L. (1753) in rats

  Abdel Halim Harrath1, Manel Jemai Ben Ali2, Amor Hedfi2 and Mossadok Ben-Attia2

  PDF HTML

• Re-examinations and post-grant proceedings in patent prosecution before the US patent and trademark office

  Abe Hershkovitz

  PDF HTML

• Process Raman spectroscopy for in-line monitoring of mammalian cell cultures in real time

  Alexander Pitters

  PDF HTML

• Evidence based research for quality control of Indian medicinal plants using HRMS and hyphenated LC/MS instruments

  Brijesh Kumar, Awantika Singh, Renu Pandey, Vikas Bajpai, Preeti Chandra and Sunil Kumar

  PDF HTML

• Catalytic activity of N-terminal methionine modification in recombinant streptokinase expressed in E. coli

  Dinesh Kumar P

  PDF HTML

• Analytical strategies for the marketing approval in highly regulated markets

  Robert E Zoubek

  PDF HTML

• Comparison between bio-similar filgrastim vs. other G-CSF formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: A retrospective survey from the Rome Transplant N

  Francesco Marchesi

  PDF HTML

• Tunisian guidelines on biosimilars registration: Main requirements and issues

  Ines Fradi

  PDF HTML

• Regulatory market exclusivity issues for biologics and biosimilars

  Gregory J Glover

  PDF HTML

• Choices and challenges in developing biosimilars in the MENA region

  Marcel Bassil

  PDF HTML

• Conception of Ayurveda adverse drug reaction and pharmacovigilance: An overview

  Manjunath Ajanal

  PDF HTML

• Molecular medicine

  Prabina Kumar

  PDF HTML

• 2015: A decisive year for the Mexican biosimilars industry

  Ricardo Ibarra-Cabrera

  PDF HTML

• Product traceability of US adverse event reports in Med-Watch for multisource biologics prior to introduction of biosimilars

  Stella Stergiopoulos

  PDF HTML

• Immunosenescence in rheumatoid arthritis: Use of CD28 negative T cells to predict treatment response

  Subir Roy

  PDF HTML

• Development of bio-similar to exendin-4, a major drug for type 2 diabetes

  Sunit Maity

  PDF HTML

• High level intracellular expression of recombinant streptokinase as an inclusion body in E. coli

  Suthakaran Pichaimuthu1, Bilgimol C Joseph1 and Krishnakanth Pulicherla2

  PDF HTML

• Bio-similar development and production

  Vivek Halan

  PDF HTML

• XTEN – A biodegradable alternative to PEG enabling biopharmaceuticals with precisely controlled structure

  Volker Schellenberger

  PDF HTML

• Enforcement of biologics in Europe under the UPC

  Willem A Hoyng

  PDF HTML

• Biosimilars in Europe: The role of EMA’s guidelines

  Wolfgang A Rehmann

  PDF HTML

• In situ/real time analysis in frame of COBAC, QSPR, QSAR and SBGN as a novel tool for the biosimilarity studies and physio-chemical prognostics in the biomedicine-assisted screening and experimental toxicology and allerg

  Orehov F C and Gradov O V

  PDF HTML

• Bioequivalence study of two rizatriptan formulations after single-dose administration to healthy male volunteers using liquid chromatography-tandem mass spectrometry (LC-MS/MS)

  Ahmed H Elshafeey1, 3 and Amany O Kamel2

  PDF HTML